Ammonium vanadyl tartrate

Hematological Effects. Human volunteers (assumed body weight, 70 kg) given 0.47-1.3 mg vanadium/kg as ammonium vanadyl tartrate in capsules for 45-68 days had no hematological abnormalities as measured by white blood cell count, differential count, platelets and reticulocytes (Dimond et al. 1963). Sodium metavanadate in food for 100 days had no effect on hemoglobin levels in rats (Franke and Moxon 1937). 

No studies were located regarding the rate and extent of absorption in humans after oral exposure to vanadium. No systemic toxic effects were observed in volunteers who consumed vanadium as ammonium vanadyl tartrate in capsules, suggesting that it may be poorly absorbed (Dimond et al.1963). 

Data are available from humans regarding acute, intermediate, and chronic inhalation exposure to vanadium pentoxide and on immunologic and neurologic effects, primarily from case studies of factory workers. Data regarding acute effects are available from volunteers who ingested ammonium vanadyl tartrate in capsules for intermediate periods. No human dermal data were located. 

Vanadium Vanadyl sulfate ammonium vanadyl tartrate Body building Intestinal cramps, diarrhea black stools. 

C8H2 iiMOi,Ni,02 2 f Ammonium M Oxo-bis( (M3 malato)-di-iLi OxO bis(dioxo-molybdate(VI))) monohydrate, 43B, 1226 C8H2 aNi,016 2 f Ammonium vanadyl ( + )-tartrate monohydrate, 32B, 416 C8H28Nsi 026 2, Tetrasodium divanadyl(IV) D-tartrate L-tartrate dodecahydrate, 33B, 409... 

---